← Back to Search

Behavioural Intervention

Easy first for Language Developmental Disorders

N/A

Recruiting

Research Sponsored by University of Arizona

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be younger than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 5 sessions a week over 6 weeks.

Awards & highlights

Study Summary

This trial aims to improve language skills in preschoolers with developmental language disorders. Children receive assessments & one-on-one treatment for 6 weeks, based on their abilities. Results will show if starting with easier forms of speech helps them learn more complex ones.

Who is the study for?

This trial is for native English-speaking preschool children aged 4-6 with developmental language disorders. They must be able to attend daily treatment, have normal hearing, specific scores on language and cognition tests, clear speech articulation, and frequent grammar mistakes that need correction.Check my eligibility

What is being tested?

The study is testing conversational recasting as a teaching method to help children learn parts of grammar they struggle with. Over six weeks, the effectiveness of starting with easier or harder grammatical forms will be compared by assessing the children's use of these forms during and after treatment.See study design

What are the potential side effects?

Since this trial involves educational interventions rather than medical treatments, there are no direct physical side effects expected from conversational recasting. However, frustration or fatigue due to learning challenges could occur.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 5 sessions a week over 6 weeks.

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~5 sessions a week over 6 weeks.

This trial's timeline: 3 weeks for screening, Varies for treatment, and 5 sessions a week over 6 weeks. for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in the use of grammatical forms in untreated contexts

Change in the use of treated grammatical forms in untreated contexts

Retention of trained grammatical forms

+1 more

Secondary outcome measures

Change in spontaneous use

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Easy firstExperimental Treatment1 Intervention

Children are treated for an emergent grammatical form that is used correctly at least 60% during three pre-treatment probe sessions. This form is treated until children generalize it's use an average of 90% or more across 3 probe sessions. Their treatment target is then switched to a grammatical form that is used less than 30% correct across 3 pre-treatment probe sessions.

Group II: Hard firstActive Control1 Intervention

Children are treated for a grammatical form that is used accurately less than 30% of the time during 3 pre-treatment probe sessions. This form is treated until children generalize it's use an average of 90% or more across 3 probe sessions. Their treatment target is then switched to a grammatical form that is used less than 30% correct across 3 pre-treatment probe sessions.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of ArizonaLead Sponsor

515 Previous Clinical Trials

148,682 Total Patients Enrolled

3 Trials studying Language Developmental Disorders

590 Patients Enrolled for Language Developmental Disorders

Media Library

Conversational recasting (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05953077 — N/A

Language Developmental Disorders Research Study Groups: Hard first, Easy first

Language Developmental Disorders Clinical Trial 2023: Conversational recasting Highlights & Side Effects. Trial Name: NCT05953077 — N/A

Conversational recasting (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05953077 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any restrictions on who can participate in this research endeavor?

"Criteria for eligibility in this trial require that participants have a language developmental disorder and are within the ages of 4 to 6. 28 individuals will be admitted into this study."

Answered by AI

How many subjects are being monitored in this clinical investigation?

"Yes, the clinical trial is still enrolling participants according to records on clinicaltrials.gov. It was first posted on 6th June 2023 and has seen updates as recent as 11th July 2023. The study calls for 28 patients from 1 site in particular."

Answered by AI

Does this research protocol accept participants over the age of forty-five?

"Prospective enrollees for this clinical trial must be aged between 4 and 6 years old. Additionally, there are 35 medical trials catering to minors and 8 that specialize in elderly care."

Answered by AI

Are individuals still being enrolled for this clinical experiment?

"Affirmative. Clinicaltrials.gov details that this experiment is actively seeking out volunteers, with the initial post dated June 7th 2023 and most recently updated on July 11th 2023. 28 participants need to be enrolled from 1 medical site in total."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Effect of Prior Learning on Treatment of Morpheme Errors

2023. "The Effect of Prior Learning on Treatment of Morpheme Errors". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05953077.

All > Tucson